Etoricoxib in the treatment of active sacroiliitis in patients with axial spondyloarthritis, including ankylosing spondylitis

Etoricoxib in the treatment of active sacroiliitis in patients with axial spondyloarthritis, including ankylosing spondylitis

AIM. To study a trend in active sacroiliitis (ASI) in patients with axial spondyloarthritis (axSpA) during different short-term regimens using etoricoxib (ET) 90 mg. MATERIALS AND METHODS. Forty patients with axSpA, including 30 with ankylosing spondyloarthritis), and ASI (sacroiliac joint (SIJ) ost...

Full description

Bibliographic Details
Main Authors: I Z Gaĭdukova, A P Rebrov, I F Nam, N V Kirsanova
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2014-12-01
Series:Терапевтический архив
Subjects:
axial spondyloarthritis
ankylosing spondylitis
sacroiliitis
non-steroidal anti-inflammatory drugs
etoricoxib
Online Access:https://ter-arkhiv.ru/0040-3660/article/view/31607

Internet

https://ter-arkhiv.ru/0040-3660/article/view/31607

Similar Items